EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies

S Arraki Zava iD, F Maizaud iD, H Sayadi, Y Fromage iD, P Marquet iD, J B Woillard iD, C Monchaud iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von S Arraki Zava und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Toxicology and Pharmacovigilance Department, Limoges University Hospital, Limoges, France. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Liver Transplantation, Kidney Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In lifelong immunosuppressive therapy, missed doses of prolonged‐release tacrolimus are almost inevitable and may reduce drug exposure, compromising transplant outcomes. Using pharmacokinetic models, we simulated delayed and missed doses in virtual kidney and liver transplant recipients. Our simulations showed that a missed dose significantly lowers exposure, with recovery taking 2–4 days. For delays shorter than 12 h, the full dose should be taken immediately; for delays between 12 and 24 h, half the dose should be administered; for a missed dose, 150% should be given at the next intake. These strategies may help maintain therapeutic exposure and preserve transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusImmunosuppressive AgentsLiver TransplantationKidney TransplantationHumansDelayed-Action PreparationsDrug Administration ScheduleComputer SimulationModels, BiologicalGraft RejectionTransplant RecipientsTime Factors

Substanzen

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Pharmacology, Toxicology and Pharmacovigilance Department, Limoges University Hospital, Limoges, France.
  • Pharmacology and Transplantation, INSERM U1248, University of Limoges, Limoges, France.
  • Hospital-University Federation "Survival Optimization in Organ Transplantation" (FHU SUPORT), Limoges, France.

ORCID-Profile: S Arraki Zava, F Maizaud, Y Fromage, P Marquet, J B Woillard, C Monchaud

Zitieren

APA

Arraki Zava, S., Maizaud, F., Sayadi, H., Fromage, Y., Marquet, P., Woillard, J. B., & Monchaud, C. (2026). Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70157

Vancouver

Arraki Zava S, Maizaud F, Sayadi H, Fromage Y, Marquet P, Woillard JB, et al. Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70157

BibTeX
@article{ArrakiZava2026,
  author = {Arraki Zava, S and Maizaud, F and Sayadi, H and Fromage, Y and Marquet, P and Woillard, J B and Monchaud, C},
  title = {Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70157}
}
Kostenlos starten →